表紙
市場調查報告書

局部皮膚適用製劑的全球市場:產業趨勢與未來預測

Global Rx Dermatology Topical Drug Delivery Market - Industry Trends and Forecast to 2026

出版商 Data Bridge Market Research Private Limited 商品編碼 861656
出版日期 內容資訊 英文 188 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
局部皮膚適用製劑的全球市場:產業趨勢與未來預測 Global Rx Dermatology Topical Drug Delivery Market - Industry Trends and Forecast to 2026
出版日期: 2019年05月01日內容資訊: 英文 188 Pages
簡介

本報告提供全球局部皮膚適用製劑──皮膚科處方藥 (外用藥)的藥物輸送──的市場相關分析,提供市場基本結構和促進·阻礙因素,整體市場規模趨勢預測 (今後8年份),各產品種類·各用途·各類別·各地區的詳細趨勢,企業間的競爭狀態,主要企業簡介等調查。

第1章 簡介

第2章 市場區隔

第3章 市場概要

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 課題

第4章 摘要整理

第5章 重要考察

第6章 全球局部皮膚適用製劑的市場:各產品種類

  • 概要
  • 固態
    • 粉末
    • 其他
  • 半固態
    • 奶油
    • 凝膠
    • 軟膏
    • 粘貼
    • 其他
  • 液狀
    • 溶液
    • 乳膠 (乳液)
    • 懸浮液
    • 化妝水
    • 其他

第7章 全球局部皮膚適用製劑的市場:各用途

  • 概要
  • 皮膚感染疾病
  • 皮膚炎
  • 抗老化
  • 痤瘡 (粉刺)
  • 色素過度沉澱
  • 酒糟
  • 皮膚癌
  • 乾癬
  • 灰指甲
  • 其他

第8章 全球局部皮膚適用製劑的市場:各類別

  • 概要
  • 品牌藥
  • 學名藥

第9章 全球局部皮膚適用製劑的市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第10章 全球局部皮膚適用製劑的市場:企業環境

  • 各企業市場佔有率分析:全球
  • 各企業市場佔有率分析:北美
  • 各企業市場佔有率分析:歐洲
  • 各企業市場佔有率分析:亞太地區

第11章 企業簡介

  • GLAXOSMITHKLINE
    • 企業概要
    • 市場收益額分析
    • 企業佔有率分析
    • 各地區的存在感
    • 產品系列
    • 近幾年趨勢
  • PFIZER INC.
  • GALDERMA LABORATORIES, L.P.
  • LEO PHARMA A/S
  • BAUSCH HEALTH COMPANIES INC.
  • ALLERGAN
  • 3M
  • BAYER AG
  • CIPLA INC.
  • 久光製藥
  • 科研製藥
  • THE LUBRIZOL CORPORATION

第12章 相關分析

目錄

Global Rx dermatology topical drug delivery market is projected to register a healthy CAGR of 4.2% in the forecast period 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Product Type (Semi-Solid, Liquid, Solid), Application (Skin Infections, Dermatitis, Antiaging, Acne, Hyperpigmentation, Rosacea, Skin Cancer, Psoriasis, Onychomycosis, Others), Category (Branded, Generic), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

Major growing sectors under the market segmentation are as follows:

  • In product type, the semi-solid formulations is dominating the global Rx dermatology topical drug delivery market as they are present in various forms such as ointments, creams, gel, paste and others. It is highly demanded as the semi-solid has more stability than other type.
  • On the basis of application, skin infections are dominating the market due to various novel infections or diseases are present worldwide. Skin infections may be mild or serious and may require precise medical treatment. According to the study of BMC Infectious Diseases in 2013, there were 376,262 individuals' experienced 471,550 skin and soft tissue infections (SSTIs) episodes.
  • In the category, the branded drugs are dominating the market due to the consumers demand for the branded drugs over the generic drugs. In the near future, the generic brands is growing as the branded drugs has their patent expirations and lower prices of generics are proving most affordable and decisive factor for selecting a generic product.

Market Players:

The key market players for Global Rx dermatology topical drug delivery The key market players for:

  • Galderma Laboratories, L.P.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Pfizer Inc.
  • LEO Pharma A /S
  • GlaxoSmithKline plc.
  • ALLERGAN
  • Bayer AG
  • 3M
  • Bausch Health Companies Inc.
  • The Lubrizol Corporation
  • Cipla Inc.
  • Kaken Pharmaceutical Co.,Ltd
  • Others

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 RESEARCH METHODOLOGY
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 SECONDARY SOURCES
  • 2.8 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 INCREASING PREVALENCE OF SKIN DISEASE OR CONDITION
    • 3.1.2 RISING AGING POPULATION
    • 3.1.3 GROWTH IN TOPICAL DRUG DELIVERY
    • 3.1.4 INCREASING RESEARCH AND DEVELOPMENT OF NEW DERMATOLOGICAL DRUGS
    • 3.1.5 NEW PRODUCT LAUNCHES
  • 3.2 RESTRAINTS
    • 3.2.1 WEAK REIMBURSEMENT POLICIES
    • 3.2.2 REGULATORY SCENARIO AND PRICING PRESSURE
  • 3.3 OPPORTUNITIES
    • 3.3.1 LOW BIOLOGIC PENETRATION
    • 3.3.2 INCREASED COMPETITION LEADING TO HIGH INVESTMENTS IN R&D TO INNOVATE NEW PRODUCTS
    • 3.3.3 INCREASING MERGERS AND ACQUISITIONS
    • 3.3.4 EMERGING MARKET
  • 3.4 CHALLENGES
    • 3.4.1 SIDE EFFECTS
    • 3.4.2 PRODUCT RECALL
    • 3.4.3 HIGH COMPETITION
    • 3.4.4 PENETRATION INTO THE SMALLER MARKETS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET,

BY PRODUCT TYPE 54

  • 6.1 OVERVIEW
  • 6.2 SOLID
    • 6.2.1 POWDER
    • 6.2.2 OTHERS
  • 6.3 SEMI-SOLID
    • 6.3.1 CREAMS
    • 6.3.2 GEL
    • 6.3.3 OINTMENTS
    • 6.3.4 PASTE
    • 6.3.5 OTHERS
  • 6.4 LIQUID
    • 6.4.1 SOLUTION
    • 6.4.2 EMULSION
    • 6.4.3 SUSPENSION
    • 6.4.4 LOTION
    • 6.4.5 OTHERS

7 GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 SKIN INFECTIONS
  • 7.3 DERMATITIS
  • 7.4 ANTIAGING
  • 7.5 ACNE
  • 7.6 HYPERPIGMENTATION
  • 7.7 ROSACEA
  • 7.8 SKIN CANCER
  • 7.9 PSORIASIS
  • 7.10 ONYCHOMYCOSIS
  • 7.11 OTHERS

8 GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY

  • 8.1 OVERVIEW
  • 8.2 BRANDED
  • 8.3 GENERIC

9 GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 U.S.
    • 9.2.2 CANADA
    • 9.2.3 MEXICO
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 FRANCE
    • 9.3.3 ITALY
    • 9.3.4 U.K.
    • 9.3.5 SWITZERLAND
    • 9.3.6 SPAIN
    • 9.3.7 NETHERLANDS
    • 9.3.8 RUSSIA
    • 9.3.9 TURKEY
    • 9.3.10 BELGIUM
    • 9.3.11 REST OF EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 JAPAN
    • 9.4.2 CHINA
    • 9.4.3 INDIA
    • 9.4.4 SOUTH KOREA
    • 9.4.5 AUSTRALIA
    • 9.4.6 THAILAND
    • 9.4.7 MALAYSIA
    • 9.4.8 SINGAPORE
    • 9.4.9 INDONESIA
    • 9.4.10 PHILIPPINES
    • 9.4.11 REST OF ASIA-PACIFIC
  • 9.5 SOUTH AMERICA
    • 9.5.1 BRAZIL
    • 9.5.2 REST OF SOUTH AMERICA

  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 SOUTH AFRICA
    • 9.6.2 REST OF MIDDLE EAST & AFRICA

10 GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, COMPANY LANDSCAPE

  • 10.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 10.3 COMPANY SHARE ANALYSIS: EUROPE
  • 10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

11 COMPANY PROFILES

  • 11.1 GLAXOSMITHKLINE
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 REVENUE ANALYSIS
    • 11.1.3 COMPANY SHARE ANALYSIS
    • 11.1.4 GEOGRAPHICAL PRESENCE
    • 11.1.5 PRODUCT PORTFOLIO
    • 11.1.6 RECENT DEVELOPMENT
  • 11.2 PFIZER INC.
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 REVENUE ANALYSIS
    • 11.2.3 COMPANY SHARE ANALYSIS
    • 11.2.4 GEOGRAPHICAL PRESENCE
    • 11.2.5 PRODUCT PORTFOLIO
    • 11.2.6 RECENT DEVELOPMENTS
  • 11.3 GALDERMA LABORATORIES, L.P.
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 COMPANY SHARE ANALYSIS
    • 11.3.3 GEOGRAPHICAL PRESENCE
    • 11.3.4 PRODUCT PORTFOLIO
    • 11.3.5 RECENT DEVELOPMENTS
  • 11.4 LEO PHARMA A/S
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 REVENUE ANALYSIS
    • 11.4.3 COMPANY SHARE ANALYSIS
    • 11.4.4 GEOGRAPHICAL PRESENCE
    • 11.4.5 PRODUCT PORTFOLIO
    • 11.4.6 RECENT DEVELOPMENTS

  • 11.5 BAUSCH HEALTH COMPANIES INC.
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 REVENUE ANALYSIS
    • 11.5.3 COMPANY SHARE ANALYSIS
    • 11.5.4 GEOGRAPHICAL PRESENCE
    • 11.5.5 PRODUCT PORTFOLIO
    • 11.5.6 RECENT DEVELOPMENT
  • 11.6 ALLERGAN
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 REVENUE ANALYSIS
    • 11.6.3 COMPANY SHARE ANALYSIS
    • 11.6.4 GEOGRAPHICAL PRESENCE
    • 11.6.5 PRODUCT PORTFOLIO
    • 11.6.6 RECENT DEVELOPMENTS
  • 11.7 3M
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 REVENUE ANALYSIS
    • 11.7.3 GEOGRAPHICAL PRESENCE
    • 11.7.4 PRODUCT PORTFOLIO
    • 11.7.5 RECENT DEVELOPMENT
  • 11.8 BAYER AG
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 REVENUE ANALYSIS
    • 11.8.3 GEOGRAPHICAL PRESENCE
    • 11.8.4 PRODUCT PORTFOLIO
    • 11.8.5 RECENT DEVELOPMENTS
  • 11.9 CIPLA INC.
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 REVENUE ANALYSIS
    • 11.9.3 GEOGRAPHICAL PRESENCE
    • 11.9.4 PRODUCT PORTFOLIO
    • 11.9.5 RECENT DEVELOPMENT
  • 11.10 HISAMITSU PHARMACEUTICAL CO., INC.
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 REVENUE ANALYSIS
    • 11.10.3 GEOGRAPHICAL PRESENCE
    • 11.10.4 PRODUCT PORTFOLIO
    • 11.10.5 RECENT DEVELOPMENT

  • 11.11 KAKEN PHARMACEUTICAL CO.,LTD.
    • 11.11.1 COMPANY OVERVIEW
    • 11.11.2 REVENUE ANALYSIS
    • 11.11.3 GEOGRAPHICAL PRESENCE
    • 11.11.4 PRODUCT PORTFOLIO
    • 11.11.5 RECENT DEVELOPMENTS
  • 11.12 THE LUBRIZOL CORPORATION
    • 11.12.1 COMPANY OVERVIEW
    • 11.12.2 GEOGRAPHICAL PRESENCE
    • 11.12.3 PRODUCT PORTFOLIO
    • 11.12.4 RECENT DEVELOPMENT

12 RELATED REPORTS

LIST OF TABLES

  • TABLE 1: NUMBER OF FORMULATION COMPONENTS FOR TOPICAL DRUG PRODUCTS MENTIONED BELOW:
  • TABLE 2: NUMBER AND DISTRIBUTION OF PERSONS AGED 60 YEARS OR OVER BY REGION, IN 2017 AND 2050
  • TABLE 3: LIST OF APPROVED TOPICAL DRUGS
  • TABLE 4: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE , 2017-2026 (USD MILLION)
  • TABLE 5: GLOBAL SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6: GLOBAL SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 7: GLOBAL SEMI-SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8: GLOBAL SEMI-SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 9: GLOBAL LIQUID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10: GLOBAL LIQUID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 11: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION , 2017-2026 (USD MILLION)
  • TABLE 12: GLOBAL SKIN INFECTIONS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 13: GLOBAL DERMATITIS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 14: GLOBAL ANTIAGING IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15: GLOBAL ACNE IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16: GLOBAL HYPERPIGMENTATION IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 17: GLOBAL ROSACEA IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18: GLOBAL SKIN CANCER IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19: GLOBAL PSORIASIS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20: GLOBAL ONYCHOMYCOSIS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21: GLOBAL OTHERS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 22: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY , 2017-2026 (USD MILLION)
  • TABLE 23: GLOBAL BRANDED IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 24: GLOBAL GENERIC IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 25: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26: NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 27: NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 28: NORTH AMERICA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 29: NORTH AMERICA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 30: NORTH AMERICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 31: NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 32: NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 33: U.S. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 34: U.S. SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 35: U.S. LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 36: U.S. SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 37: U.S. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 38: U.S. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 39: CANADA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 40: CANADA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 41: CANADA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 42: CANADA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 43: CANADA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 44: CANADA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 45: MEXICO RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 46: MEXICO SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 47: MEXICO LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 48: MEXICO SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 49: MEXICO RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 50: MEXICO RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 51: EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 52: EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 53: EUROPE SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 54: EUROPE LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 55: EUROPE SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 56: EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 57: EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 58: GERMANY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 59: GERMANY SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 60: GERMANY LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 61: GERMANY SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 62: GERMANY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 63: GERMANY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 64: FRANCE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 65: FRANCE SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 66: FRANCE LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 67: FRANCE SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 68: FRANCE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 69: FRANCE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 70: ITALY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 71: ITALY SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 72: ITALY LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 73: ITALY SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 74: ITALY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 75: ITALY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 76: U.K. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 77: U.K. SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 78: U.K. LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 79: U.K. SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 80: U.K. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 81: U.K. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 82: SWITZERLAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 83: SWITZERLAND SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 84: SWITZERLAND LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 85: SWITZERLAND SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 86: SWITZERLAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 87: SWITZERLAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 88: SPAIN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 89: SPAIN SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 90: SPAIN LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 91: SPAIN SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 92: SPAIN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 93: SPAIN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 94: NETHERLANDS RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 95: NETHERLANDS SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 96: NETHERLANDS LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 97: NETHERLANDS SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 98: NETHERLANDS RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 99: NETHERLANDS RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 100: RUSSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 101: RUSSIA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 102: RUSSIA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 103: RUSSIA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 104: RUSSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 105: RUSSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 106: TURKEY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 107: TURKEY SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 108: TURKEY LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 109: TURKEY SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 110: TURKEY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 111: TURKEY RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 112: BELGIUM RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 113: BELGIUM SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 114: BELGIUM LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 115: BELGIUM SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 116: BELGIUM RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 117: BELGIUM RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 118: REST OF EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 119: ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 120: ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 121: ASIA-PACIFIC SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 122: ASIA-PACIFIC LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 123: ASIA-PACIFIC SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 124: ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 125: ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 126: JAPAN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 127: JAPAN SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 128: JAPAN LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 129: JAPAN SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 130: JAPAN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 131: JAPAN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 132: CHINA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 133: CHINA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 134: CHINA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 135: CHINA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 136: CHINA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 137: CHINA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 138: INDIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 139: INDIA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 140: INDIA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 141: INDIA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 142: INDIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 143: INDIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 144: SOUTH KOREA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 145: SOUTH KOREA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 146: SOUTH KOREA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 147: SOUTH KOREA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 148: SOUTH KOREA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 149: SOUTH KOREA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 150: AUSTRALIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 151: AUSTRALIA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 152: AUSTRALIA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 153: AUSTRALIA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 154: AUSTRALIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 155: AUSTRALIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 156: THAILAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 157: THAILAND SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 158: THAILAND LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 159: THAILAND SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 160: THAILAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 161: THAILAND RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 162: MALAYSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 163: MALAYSIA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 164: MALAYSIA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 165: MALAYSIA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 166: MALAYSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 167: MALAYSIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 168: SINGAPORE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 169: SINGAPORE SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 170: SINGAPORE LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 171: SINGAPORE SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 172: SINGAPORE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 173: SINGAPORE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 174: INDONESIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 175: INDONESIA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 176: INDONESIA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 177: INDONESIA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 178: INDONESIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 179: INDONESIA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 180: PHILIPPINES RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 181: PHILIPPINES SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 182: PHILIPPINES LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 183: PHILIPPINES SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 184: PHILIPPINES RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 185: PHILIPPINES RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 186: REST OF ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 187: SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 188: SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 189: SOUTH AMERICA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 190: SOUTH AMERICA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 191: SOUTH AMERICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 192: SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 193: SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 194: BRAZIL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 195: BRAZIL SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 196: BRAZIL LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 197: BRAZIL SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 198: BRAZIL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 199: BRAZIL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 200: REST OF SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 201: MIDDLE EAST & AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 202: MIDDLE EAST & AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 203: MIDDLE EAST & AFRICA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 204: MIDDLE EAST & AFRICA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 205: MIDDLE EAST & AFRICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 206: MIDDLE EAST & AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 207: MIDDLE EAST & AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 208: SOUTH AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 209: SOUTH AFRICA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 210: SOUTH AFRICA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 211: SOUTH AFRICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 212: SOUTH AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 213: SOUTH AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
  • TABLE 214: REST OF SOUTH AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: SEGMENTATION
  • FIGURE 2: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: GEOGRAPHICAL SCOPE
  • FIGURE 3: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: DATA TRIANGULATION
  • FIGURE 4: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: DROC ANALYSIS
  • FIGURE 5: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 6: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 7: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 8: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET
  • FIGURE 9: TOTAL NUMBER OF COMPANIES WITH ACTIVE PIPELINE (2015 TO 2017)
  • FIGURE 10: TOTAL NUMBER OF COMPANIES WITH ACTIVE PIPELINE (2012-2017)
  • FIGURE 11: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: SEGMENTATION
  • FIGURE 12: NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 13: INCREASING PREVALENCE OF SKIN DISEASES OR CONDITIONS, RISING AGING POPULATION AND GROWTH IN TOPICAL DRUG DELIVERY ARE EXPECTED TO DRIVE THE GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 14: SEMI-SOLID IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL DERMATOLOGY DRUG DELIVERY MARKET IN 2019 & 2026
  • FIGURE 15: ASIA-PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 16: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: BY PRODUCT TYPE, 2018
  • FIGURE 17: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: BY APPLICATION, 2018
  • FIGURE 18: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: BY CATEGORY, 2018
  • FIGURE 19: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: SNAPSHOT (2018)
  • FIGURE 20: NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: SNAPSHOT (2018)
  • FIGURE 21: EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: SNAPSHOT (2018)
  • FIGURE 22: ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: SNAPSHOT (2018)
  • FIGURE 23: SOUTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: SNAPSHOT (2018)
  • FIGURE 24: MIDDLE EAST & AFRICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: SNAPSHOT (2018)
  • FIGURE 25: GLOBAL RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 26: NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 27: EUROPE RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 28: ASIA-PACIFIC RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE 2018 (%)
Back to Top